Clovis Oncology
CLVS
#10297
Rank
S$15.25 M
Marketcap
S$0.11
Share price
0.00%
Change (1 day)
-95.24%
Change (1 year)

Revenue for Clovis Oncology (CLVS)

Revenue in 2022 (TTM): S$0.18 Billion

According to Clovis Oncology's latest financial reports the company's current revenue (TTM ) is S$0.17 Billion. In 2021 the company made a revenue of S$0.20 Billion a decrease over the revenue in the year 2020 that were of S$0.21 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Clovis Oncology from 2010 to 2022

Annual revenue

Year Revenue Change
2022 (TTM) S$0.18 B-8.65%
2021 S$0.20 B-7.6%
2020 S$0.21 B12.89%
2019 S$0.19 B47.95%
2018 S$0.13 B75.52%
2017 S$74.24 M65668.76%
2016 S$0.11 M
2015 N/A-100%
2014 S$18 M
2013 N/A
2012 N/A
2011 N/A
2010 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
BioMarin Pharmaceutical
BMRN
S$4.00 B 2,225.95%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
S$75.32 B 43,597.61%๐Ÿ‡ฌ๐Ÿ‡ง UK
Pfizer
PFE
S$81.36 B 47,100.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$119.41 B 69,174.02%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
S$77.29 B 44,738.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
S$77.00 B 44,569.49%๐Ÿ‡บ๐Ÿ‡ธ USA